Thank you for your interest in our SAINT Neuromodulation System.

If you or your loved one is in crisis and need immediate support, please call 988 or 911.

We are working to launch the SAINT Neuromodulation System globally now that we have FDA clearance for this breakthrough technology. During this period, SAINT treatment may be available via the ongoing research being conducted at the following site(s)

Visit Stanford Trial Catalyst

Rx only.
Patient Safety Information:
The SAINT® Neuromodulation System is indicated for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. You should not receive SAINT Neuromodulation System therapy if you have any non-removable metal material anywhere in your head or within 30cm of the stimulation device, you have an active or inactive implanted device, or you have a catheter, pump, or other device that may interact with stimulation. Side effects may include headache, anxiety, fatigue, and discomfort from stimulation. Other side effects, including seizure and worsening depression or suicidal thoughts, have occurred with similar devices and may occur. Not all patients will have improvement of depression symptoms. Available by prescription only.